Neurocrine Biosciences (NBIX) Reports Q3 Loss of $0.13
Tweet
Share
E-mail
Get Alerts NBIX Hot Sheet
Price: $139.49 -1.94%
Revenue Growth %: +30.8%
Financial Fact:
Total revenues: 0
Today's EPS Names:
OCCI, ALZN, ASPU, More
Revenue Growth %: +30.8%
Financial Fact:
Total revenues: 0
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Neurocrine Biosciences (NASDAQ: NBIX) reported Q3 EPS of ($0.13), versus ($0.43) reported last year.
For earnings history and earnings-related data on Neurocrine Biosciences (NBIX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Stitch Fix (SFIX) Tops Q4 EPS by 4c; Offers Guidance
- Capitol Federal Financial names William Skrobacz Jr. as president
- Unity Bancorp CEO to retire in 2027, president to take over
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
